CIP
MRK icon

Capital Insight Partners’s Merck MRK Stock Holding History

Capital Insight Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,972
Closed -$244K – 161
2024
Q2 		$244K Sell
1,972
-175
-8% -$22.5K 0.05% 145
2024
Q1 		$283K Sell
2,147
-9
-0.4% -$1.11K 0.05% 147
2023
Q4 		$235K Sell
2,156
-47
-2% -$4.88K 0.05% 156
2023
Q3 		$227K Sell
2,203
-95
-4% -$10.2K 0.05% 154
2023
Q2 		$265K Sell
2,298
-242
-10% -$27.5K 0.06% 148
2023
Q1 		$270K Buy
2,540
+284
+13% +$30.7K 0.06% 148
2022
Q4 		$250K Buy
+2,256
New +$231K 0.06% 146

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Insight Partners's MRK Position: Q3 2024 in Review

Capital Insight Partners sold out of Merck (MRK) in Q3 2024, closing a stake of 1,972 shares — an estimated $244K sold.

Capital Insight Partners first reported a position in MRK in Q4 2022 and held it in 7 quarters. The position peaked at $283K in Q1 2024. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Capital Insight Partners reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Capital Insight Partners sold 1,972 Merck shares in Q3 2024, an estimated $244K.
  • Capital Insight Partners first reported a position in Merck in Q4 2022 and held it in 7 quarters.
  • Capital Insight Partners's Merck position peaked at $283K in Q1 2024.
  • 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Capital Insight Partners's 13F filing for Q3 2024, filed 9 Oct 2024.